Charles River Laboratories International, Inc. (CRL) vs DENTSPLY SIRONA Inc. (XRAY)
CRL leads on 7 of 13 compared metrics.
A side-by-side comparison of Charles River Laboratories International, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CRL
Charles River Laboratories International, Inc.
$187.51Healthcare
XRAY
DENTSPLY SIRONA Inc.
$10.09Healthcare
Total return — CRL vs XRAY
growth of $100 · last 26yCRL +752.3%XRAY -3.5%CRL compounded faster
Log scale — wide-divergence pair
CRL XRAY
CRL vs XRAY: by the numbers
- •CRL is the larger company ($9.03B vs $2.02B market cap).
- •Both run net losses; CRL's is the smaller (-4.59% vs -17.06% net margin).
- •CRL grew revenue faster over the past five years (5.77% vs 1.12% CAGR).
- •XRAY pays a dividend (4.76% yield) while CRL does not currently pay one.
Which is better, CRL or XRAY?
Metric tally: CRL 7 · XRAY 6It depends on what you're optimizing for:
GrowthCRL(faster 5Y revenue CAGR)
QualityCRL(higher ROIC)
Valuation
| Metric | CRL | XRAY |
|---|---|---|
| Forward P/E | 15.21 | 7.11● |
| P/S ratio | 2.28 | 0.55● |
| P/B ratio | 3.12 | 1.53● |
| EV / EBITDA | 41.45 | — |
| FCF yield | 4.26% | 5.16%● |
Profitability
| Metric | CRL | XRAY |
|---|---|---|
| Gross margin | 31.86% | 48.93%● |
| Operating margin | 11.77%● | 5.87% |
| Net margin | -4.59%● | -17.06% |
| ROE | -6.28%● | -47.65% |
| ROIC | 8.36%● | 5.67% |
Dividends
| Metric | CRL | XRAY |
|---|---|---|
| Dividend yield | — | 4.76% |
Growth (annualized)
| Metric | CRL | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | 5.77%● | 1.12% |
| EPS CAGR (5Y) | -40.99% | -0.93%● |
| FCF CAGR (5Y) | -3.98%● | -29.96% |
| Total return CAGR (5Y) | -11.83%● | -29.72% |
Frequently asked
- Which is better, CRL or XRAY?
- It depends on your goal. growth: CRL (faster 5Y revenue CAGR); quality: CRL (higher ROIC). Across all compared metrics, CRL leads 7 to 6.
- Which has grown faster, CRL or XRAY?
- Over the past five years, CRL grew revenue faster — CRL at a 5.77% CAGR versus XRAY at 1.12%.
- Does CRL or XRAY pay a bigger dividend?
- XRAY pays a dividend (4.76% yield) while CRL does not currently pay one.
- Which has been the better investment, CRL or XRAY?
- Over the past 10-year, CRL delivered the higher annualized total return — CRL at 8.26% versus XRAY at -15.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Charles River Laboratories International P/E ratioDENTSPLY SIRONA P/E ratioCharles River Laboratories International dividend yieldDENTSPLY SIRONA dividend yieldCharles River Laboratories International ROEDENTSPLY SIRONA ROECharles River Laboratories International operating marginDENTSPLY SIRONA operating marginCharles River Laboratories International revenue growthDENTSPLY SIRONA revenue growthCharles River Laboratories International free cash flowDENTSPLY SIRONA free cash flow
Charles River Laboratories International & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.